教室年報

Last updated: Dec 7, 2020

原著論文(英文)

Epub ahead of print

  • Yamamoto M, Mori T, Toki T, Itosu Y, Kubo Y, Yokota I, Morimoto Y. The relationships of cerebral and somatic oxygen saturation with physiological parameters in pediatric cardiac surgery with cardiopulmonary bypass: analysis using the random-effects model. Pediatr Cardiol. [Epub ahead of print]
  • Taki K, Yokota I, Fukumoto T, Iwasaki S, Fujisawa S, Takahashi M, Negishi S, Hayasaka K, Sato K, Oguri S, Nishida M, Sugita J, Konno S, Saito T, Teshima T. SARS-CoV-2 detection by fluorescence loop-mediated isothermal amplification with and without RNA extraction. J Infect Chemother. [Epub ahead of print]
  • Yokota I, Shane PY, Okada K, Unoki Y, Yang Y, Inao T, Sakamaki K, Iwasaki S, Hayasaka K, Sugita J, Nishida M, Fujisawa S, Teshima T. Mass screening of asymptomatic persons for SARS-CoV-2 using saliva. Clin Infect Dis. [Epub ahead of print]
  • Chinen Y, Tanba K, Takagi R, Uchiyama H, Uoshima N, Shimura K, Fuchida SI, Kiyota M, Nakao M, Tsukamoto T, Shimura Y, Kobayashi T, Horiike S, Wada K, Shimazaki C, Kaneko H, Kobayashi Y, Taniwaki M, Yokota I, Kuroda J; Kyoto Clinical Hematology Study Group investigators. Second primary malignancy after rituximab-containing immunochemotherapy for diffiuse large B cell lymphoma. Leuk Lymphoma. [Epub ahead or print]
  • Nakamura H, Fujieda Y, Tarumi M, Kitakawa H, Hisada R, Nakagawa I, Noguchi A, Kurita T, Kataoka H, Kasahara H, Amasaki Y, Yokota I, Atsumi T. Calcineurin inhibitors for adult-onset Still’s disease: a multicentre retrospective cohort study. Clin Exp Rheumatol. [Epub ahead of print]

2020年

  • Hane Y, Tsuchikawa T, Nakamura T, Hatanaka KC, Saito T, Tanaka K, Nakanishi Y, Asano T, Noji T, Okamura K, Shichinohe T, Yokota I, Hatanaka Y, Hirano S. Immunological gene signature associated with the tumor microenvironment of pancreatic cancer after neoadjuvant chemotherapy. Pancreas. 2020; 49: 1240-1245.
  • Abe T, Yokota T, Fukushima A, Kakutani N, Katayama T, Shirakawa R, Maekawa S, Nambu H, Obata Y, Yamanashi K, Nakano I, Takada S, Yokota I, Okita K, Kinugawa S, Anzai T. Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction. Cardiovasc Diabetol. 2020;19:142.
  • Watanabe-Hosomi A, Mizuta I, Koizumi T, Yokota I, Mukai M, Hamano A, Kondo M, Fujii A, Matsui M, Matsuo K, Ito K, Teramukai S, Yamada K, Nakagawa M, Mizuno T. Effect of lomerizine hydrochloride on preventing strokes in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Clin Neuropharmacol. 2020; 43: 146-150.
  • Noguchi A, Hosokawa K, Amaya F, Yokota I. Factors related to memory absence and delusional memories in patients in intensive care units managed with light sedation. Intensive Crit Care Nurs. 2020;59:102830
  • Miyake M, Matsuyama H, Teramukai S, Kinoshita F, Yokota I, Matsumoto H, Shimada K, Kinjyo M, Shimokama T, Okumura K, Yomenori M, Enokida H, Nakagawa M, Nakai Y, Fujimoto K; Nishinihon Uro-oncology Extensive Collaboration group. A new risk stratification model for intravesical recurrence, disease progression, and cancer-specific death in patients with non-muscle invasive bladder cancer: the J-NICE risk tables. Int J Clin Oncol. 2020;25:1364-1376.
  • Iwasaki K, Inoue M, Kasahara Y, Tsukuda K, Kawahara H, Yokota I, Kondo E, Iwasaki N, Yasuda K. Inclination of Blumensaat’s line influences on the accuracy of the quadrant method in evaluation for anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2020; 28: 1885-1893.
  • Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Kobayashi T, Uebayashi M, Takagi R, Yokota I, Shimamura T, Sakamoto N. Analysis of the optimal psoas muscle mass index cut-off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people. Hepatol Res. 2020; 50:715-725.
  • Yoshikawa Y, Ueta M, Fukuoka H, Inatomi T, Yokota I, Teramukai S, Yokoi N, Kinoshita S, Tajiri K, Ikeda T, Sotozono C. Long-term progression of ocular surface disease in Stevens-Johnson syndrome and toxic epidermal necrolysis. Cornea. 2020; 39: 745-753.
  • Akutsu T, Yokota I, Watanabe K, Sakurada K. Development of a multiplex RT-PCR assay and statistical evaluation of its use in forensic identification of vaginal fluid. Leg Med(Tokyo). 2020; 45: 101715.
  • Kato M, Kaneko Y, Tanaka Y, Inoo M, Kobayashi-Haraoka H, Amano K, Miyata M, Murakawa Y, Yasuoka H, Hirata S, Nagasawa H, Tanaka E, Miyasaka N, Yamanaka H, Yamamoto K, Yokota I, Atsumi T, Takeuchi T. Predictive value of serum amyloid A levels for requirement of concomitant methotrexate in tocilizumab initiation: A post-hoc analysis of the SURPRISE study. Mod Rheumatol. 2020; 30: 442-449.
  • Kawamura T, Takeuchi Y, Yokota I, Takagaki N. Indications for cold polypectomy stratified by the colorectal polyp size: a systematic review and meta-analysis. J Anus Rectum Colon. 2020;4:67-78.
  • Kawamura T, Inoue T, Shinomiya R, Sakai H, Amamiya K, Sakiyama N, Shirakawa A, Okada Y, Sanada K, Nakase K, Mandai K, Suzuki A, Kamaguchi M, Morita A, Nishioji K, Tanaka K, Uno K, Yokota I, Kobayashi M, Yasuda K. Significance of fecal hemoglobin concentration for predicting risk of colorectal cancer after colonoscopy. JGH Open. 2020; 4: 898-902.
  • Itoi M, Kitazawa K, Yokota I, Wakimasu K, Cho Y, Nakamura Y, Hieda O, Teramukai S, Kinoshita S, Sotozono C. Anterior and posterior ratio of corneal surface areas: A novel index for detecting early stage keratoconus. PLoS One. 2020;15:e0231074.
  • Fujikawa K, Teramukai S, Yokota I, Daimon T. A Bayesian basket trial design that borrows information across strata based on the similarity between the posterior distributions of the response probability.
    Biom J. 2020;62:330-338.
  • Kida T, Tanaka T, Yokota I, Tamagaki K, Sagawa T, Kadoya M, Yamada T, Fujioka K, Wada M, Kohno M, Hiraoka N, Omoto A, Fukuda W, Kawahito Y. Association between preexisting lung involvements and the risk of diffuse alveolar hemorrhage in patients with microscopic polyangiitis: a multi-center retrospective cohort study. Mod Rheumatol. 2020;30:338-344.
  • Wakimasu K, Kitazawa K, Kayukawa K, Yokota I, Inatomi T, Hieda O, Sotozono C, Kinoshita S. Five-year follow-up outcomes after Descemet’s stripping automated endothelial keratoplasty: a retrospective study. BMJ Open Ophthalmol. 2020; 5: e000354.
  • Kanbayashi Y, Sakaguchi K, Ishikawa T, Ouchi Y, Nakatsukasa K, Tabuchi Y, Kanehisa F, Hiramatsu M, Takagi R, Yokota I, Katoh N, Taguchi T. Comparison of the efficacy of cryotherapy and compression therapy for preventing nanoparticle albumin-bound paclitaxel-induced peripheral neuropathy: a prospective self-controlled trial. Breast 2020; 49: 219-224.
  • Ushigome E, Kitagawa N, Kitae A, Kimura T, Iwai K, Oyabu C, Ushigome H, Yokota I, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Seasonal variation in home blood pressure and its relationship with room temperature in patients with type 2 diabetes. Diab Vasc Dis Res. 2020; 17:1479164119883986.
  • Kaneshita S, Kida T, Yokota I, Nagahara H, Seno T, Wada M, Kohno M, Kawahito Y. Risk factors for cytomegalovirus disease with cytomegalovirus re-activation in patients with rheumatic disease. Mod Rheumatol. 2020;30:109-115.

2019年

  • Ushigome E, Oyabu C, Shiraishi M, Kitagawa N, Kitae A, Iwai K, Ushigome H, Yokota I, Hamaguchi M, Yamazaki M, Fukui M. Evaluation of the efficacy of simplified nutritional instructions from physicians on dietary salt restriction for patients with type 2 diabetes mellitus consuming excessive salt: protocol for a randomized controlled trial. Trials. 2019;20:761.
  • Kitagawa N, Ushigome E, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Kitagawa N, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Isolated high home systolic blood pressure in patients with type 2 diabetes is a prognostic factor for the development of diabetic nephropathy: KAMOGAWA-HBP study. Diabetes Res Clin Pract. 2019;158:107920
  • Taniguchi Y, Kitamura A, Ishizaki T, Fujiwara Y, Shinozaki T, Seino S, Mitsutake S, Suzuki H, Yokoyama Y, Abe T, Ikeuchi T, Yokota I, Matsuyama Y, Shinkai S. Association of trajectories of cognitive function with cause-specific mortality and medical and long-term care costs. Geriatr Gerontol Int. 2019; 19: 1236-1242.
  • Yamaguchi J, Chinen Y, Takimoto-Shimomura T, Nagata H, Muramatsu A, Kuriyama K, Ohshiro M, Hirakawa Y, Iwai T, Uchiyama H, Uoshima N, Kaneko H, Nakao M, Tsukamoto T, Shimura Y, Kobayashi T, Horiike S, Yokota I, Kuroda J; KOTOSG Investigators. Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphoma. Leuk Lymphoma. 2019; 60:3434-3441.
  • Yamauchi Y, Nakamura A, Takahashi K, Takase T, Yamamoto C, Yokota I, Atsumi T, Miyoshi H. Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragli ozin. Endocr J. 2019; 66:995-1000.
  • Takai S, Nakanishi N, Yokota I, Imai K, Yamada A, Kawasaki T, Okada T, Sawada T, Fujita H, Matoba S. Clot regression effects of rivaroxaban in the treatment of venous thromboembolism in patients with cancer (CRERIT-VTE cancer): study protocol. BMJ Open. 2019;9:e031698.
  • Iwai K, Ushigome E, Matsumoto S, Kitagawa N, Ushigome H, Yokota I, Asano M, Hamaguchi M, Yamazaki M, Fukui M. Home blood pressure is associated with cognitive impairment among elderly patients with type 2 diabetes: KAMOGAWA-HBP study. Diab Vasc Dis Res. 2019;16:506-512.
  • Okamura T, Ushigome E, Kitagawa N, Oyabu C, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Maximum morning home systolic blood pressure is an indicator of the development of diabetic nephropathy: The KAMOGAWA-HBP study. J Diabetes Investig. 2019;10:1543-1549.
  • Iehara T, Yoneda A, Yokota I, Takahashi H, Teramukai S, Kamijyo T, Nakazawa A, Takimoto T, Kikuta A, Yagyu S, Ikeda H, Nakagawara A, Tajiri T, Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children’s Cancer Group Neuroblastoma Committee. Pediatr Blood Cancer. 2019; 66:e27914
  • Shimizu M, Amaya F, Kinoshita M, Yamasaki M, Yokota I, Sawa T. Reduction of the rocuronium-induced withdrawal reflex by MR13A10A, a generic rocuronium with a novel solution: A randomized, controlled study. PLoS One. 2019;14:e0223947.
  • Zen Y, Chiyonobu T, Yuge M, Yokota I, Morimoto M, Teramukai S, Hosoi H. Gender differences in occurrence of behavioral and emotional problems at the lower grades of elementary school: association with developmental and behavioral characteristics at 5years. Brain Dev. 2019;41:760-768.
  • Nakao R, Konishi E, Fujiwara H, Otsuji E, Yokota I, Urata Y, Yanagisawa A. Residual cancer volume predicts clinical outcome in patients with esophageal squamous cell carcinoma after neoadjuvant chemotherapy. Int J Surg Pathol. 2019;27:713-721.
  • Sagawa T, Kida T, Inaba T, Yokota I, Sagawa R, Kasahara A, Kaneshita S, Inoue T, Nagahara H, Fujioka K, Wada M, Kohno M, Kawahito Y. Utility of coagulation markers for the prediction of rapidly progressive interstitial lung disease in patients with dermatomyositis. Lung. 2019;197:437-442.
  • Sakaguchi K, Ono H, Nakatsukasa K, Ishikawa T, Hasegawa Y, Takahashi M, Niikura N, Koizumi K, Sakurai T, Shigematsu H, Takahashi S, Taira S, Suzuki M, Narui K, Miura D, Yamada K, Yoshimura M, Shioya H, Konishi E, Yokota I, Imai K, Fujikawa K, Taguchi T; Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer. Medicine (Baltimore). 2019;98:e16770
  • Morio K, Maeda I, Yokota I, Niki K, Murata T, Matsumura Y, Uejima E. Risk factors for polypharmacy in elderly patients with cancer pain. Am J Hosp Palliat Care. 2019; 36:598-602.
  • Tsuboi H, Yokota I, Miyamori D, Akasaka Y, Yamada A, Ikegaya H. Age estimation based on visual parameters of the skin of cadavers. Skin Res Technol. 2019;25:532-537.
  • Mihara Y, Kado H, Yokota I, Shiotsu Y, Sonomura K, Kusaba T, Hatta T, Matoba S, Tamagaki K. Rapid weight loss with dietary salt restriction in hospitalized patients with chronic kidney disease. Sci Rep. 2019;9:8787.
  • Sowa Y, Yokota I, Fujikawa K, Morita D, Taguchi T, Numajiri T. Objective evaluation of fat tissue induration after breast reconstruction using a deep inferior epigastric perforator (DIEP) flap. J Plast Surg Hand Surg. 2019;53:125-129.
  • Yokota J, Fukutani N, Nin K, Yamanaka H, Yasuda M, Tashiro Y, Matsushita T, Suzuki Y, Yokota I, Teramukai S, Aoyama T. Association of low back pain with presenteeism in hospital nursing staff. J Occup Health. 2019;61:219-226.
  • Shinomoto M, Kasai T, Tatebe H, Kondo M, Ohmichi T, Morimoto M, Chiyonobu T, Terada N, Allsop D, Yokota I, Mizuno T, Tokuda T. Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients. PLoS One. 2019;14:e0211575.
  • Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan. Impact of advanced age on survival in patients undergoing resection of hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg. 2019; 269:692-699.
  • Noguchi A, Inoue T, Yokota I. Promoting a nursing team’s ability to notice intent to communicate in lightly sedated mechanically ventilated patients in an Intensive Care Unit: an action research study.Intensive Crit Care Nurs. 2019; 51: 64-72.
  • Goto M, Sakai K, Yokota H, Kiba M, Yoshida M, Imai H, Weiland E, Yokota I, Yamada K. Diagnostic performance of initial enhancement analysis using ultra-fastdynamic contrast-enhanced MRI for breast lesions. Eur Radiol. 2019;29:1164-1174.
  • Yokota I, Matsuyama Y. Dynamic prediction of repeated events data based on landmarking model: application to colorectal liver metastases data. BMC Med Res Methodol. 2019;30:31.
  • Yasuda H, Kataoka K, Takeyama Y, Takeda K, Ito T, Mayumi T, Isaji S, Mine T, Kitagawa M,Kiriyama S, Sakagami J, Masamune A, Inui K, Hirano K, Akashi R, Yokoe M, Sogame Y, Okazaki K, Morioka C, Kihara Y, Kawa S, Tanaka M, Andoh A, Kimura W, Nishimori I, Furuse J, Yokota I, Shimosegawa T. Usefulness of urinary trypsinogen-2 and trypsinogen activation peptide in acute pancreatitis: A multicenter study in Japan. World J Gastroenterol. 2019; 25: 107-117.
  • Kunikane H, Yokota I, Katakami N, Takeda K, Takayama K , Sawa T, Saito H, Harada M, Yokota S, Ando K, Saito Y, Ohashi Y, Eguchi K. Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). Oncol Lett. 2019; 17: 1320-1326.

2018年

  • Miyake H, Sakagami J, Yasuda H, Sogame Y, Kato R, Suwa K, Dainaka K, Takata T, Yokota I, Itoh Y. Association of fatty pancreas with pancreatic endocrine and exocrine function. PLOS One. 2018; 13: e0209448.
  • Kaibori M, Yoshii K, Yokota I. Reply to “Relative survival instead of overall survival should be used as outcome when analyzing the effect of age after treatment of hepatocellular carcinoma”. Ann Surg. 2018; 268:e76-e77.
  • Toyama T, Yoshimura A, Hayashi T, Kobatashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Iwata H. A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer. Breast Cancer. 2018; 25: 729-735.
  • Yamazaki S, Numata S, Inoue T, Itatani K, Morimoto K, Ohira S, Manabe K, Yokota I, Yaku H. Impact of right ventricular volume and function evaluated using cardiovascular magnetic resonance imaging on outcomes after surgical ventricular reconstruction. Eur J Cardiothorac Surg. 2018. 2018; 54: 867-874.
  • Kawamura T, Takeuchi Y, Asai S, Yokota I, Akamine E, Kato M, Akamatsu T, Tada K, Komeda Y, Iwatate M, Kawakami K, Nishikawa M, Watanabe D, Yamauchi A, Fukata N, Shimatani M, Ooi M, Fujita K, Sano Y, Kashida H, Hirose S, Iwagami H, Uedo N, Teramukai S, Tanaka K. A comparison of the resection rate for cold and hot snare polypectomy for 4-9 mm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study). Gut. 2018. 67: 1950-1957.
  • Kitazawa K, Itoi M, Yokota I, Wakimasu K, Cho Y, Nakamura Y, Hieda O, Kinoshita S, Sotozono C. Involvement of anterior and posterior corneal surface area imbalance in the pathological change of keratoconus. Sci Rep. 2018; 8:14993.
  • Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M , Yamaguchi Y , Yamakita S, Ueno H, Sawa T, Taguchi T, Hosokawa T, Amaya F. Classification of acute pain trajectory after breast cancer surgery identifies patients at risk for persistent pain: a prospective observational study. J Pain Res. 2018; 11: 2197-2206.
  • Kitazawa K, Wakimasu K, Kayukawa K, Yokota I, Inatomi T, Hieda O, Sotozono C, Kinoshita S. Moderately long-term safety and efficacy of repeat penetrating keratoplasty. Cornea. 2018; 37: 1255-1259.
  • Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Int J Clin Oncol. 2018. 2018; 23: 965-973.
  • Katayama K, Imai T, Abe Y, Nawa T, Maeda N, Nakanishi K, Wada H, Fukui K, Ito Y, Yokota I, Ohkawa K. Number of nodules but not dize of hepatocellular carcinoma can predict refractoriness to transarterial chemoembolization and poor prognosis. J Clin Med Res. 2018; 10: 765-771.
  • Hagiwara N, Watanabe M, Iizuka-Ohashi M, Yokota I, Toriyama S, Sukeno M, Tomosugi M, Sowa Y, Hongo F, Mikami K, Soh J, Fujito A, Miyashita H, Morioka Y, Miki T, Ukimura O, Sakai T. Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma. Cancer Lett. 2018; 431:182-189.
  • Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J. The detection of white matter alterations in obsessive-compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA). Neuropsychiatr Dis Treat. 2018; 14: 1635-1643.
  • Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Asano M, Tanaka M, Yamazaki M, Fukui M. Prognostic significance of home pulse pressure for progression of diabetic nephropathy: KAMOGAWA-HBP study. Hypertens Res. 2018; 41: 363-371.
  • Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators. Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum. Int J Hematol. 2018; 107: 541-550.
  • Ushigome E, Oyabu C, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Oda Y, Asano M, Tanaka M, Yamazaki M, Fukui M. Impact of masked hypertension on diabetic nephropathy in patients with type II diabetes: a KAMOGAWA-HBP study. J Am Soc Hypertens. 2018;12:364-371.
  • Ushigome E, Matsumoto S, Oyabu C, Kitagawa N, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Oda Y, Asano M, Tanaka M, Yamazaki M, Fukui M. Prognostic significance of day-by-day variability of home blood pressure on progression to macroalbuminuria in patients with diabetes. J Hypertens. 2018; 36: 1068-1075.
  • Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, Toda M, Hagiya M, Yokota I, Teramukai S, Sotozono C, Hamuro J. Injection of cultured cells with ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378:995-1003.
  • Mizuno Y, Tsukamoto T, Kawata E, Uoshima N, Uchiyama H, Yokota I, Maegawa S, Takimoto T, Tanba K, Matsumura-Kimoto Y, Kuwahara-Ota S, Fujibayashi Y, Yamamoto-Sugitani M, Chinen Y, Shimura Y, Horiike S, Taniwaki M, Kobayashi T, Kuroda J. Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy. Cancer Med. 2018;7:655-664.
  • Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Asano M, Tanaka M, Yamazaki M, Fukui M. Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study. J Clin Hypertens. 2018;20:472-477.
  • Yamada K, Shiraishi H, Oki E, Ishige M, Fukao T, Hamada Y, Sakai N, Ochi F, Watanabe A, Kawakami S, Kuzume K, Watanabe K, Sameshima K, Nakamagoe K, Tamaoka A, Asahina N, Yokoshiki S, Miyakoshi T, Ono K, Oba K, Isoe T, Hayashi H, Yamaguchi S, Sato N. Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan. Molecular Genetics and Metabolism Reports. 2018;15:55-63.
  • Umazume T, Yamada T, Yamada S, Ishikawa S, Furuta I, Iwano H, Murai D, Hayashi T, Okada K, Morikawa M, Yamada T, Ono K, Tsutsui H, Minakami H. Morphofunctional cardiac changes in pregnant women: associations with biomarkers. Open Heart. 2018;5:e000850.
  • Tokairin K, Kazumata K, Uchino H, Ito M, Ono K, Tatezawa R, Shindo T, Kawabori M, Nakayama N, Houkin K. Postoperative Intracerebral Hemorrhage After Combined Revascularization Surgery in Moyamoya Disease: Profiles and Clinical Associations. World Neurosurgery. 2018.
  • Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea. Journal of Diabetes Investigation. 2018.
  • Oita M, Miyoshi H, Ono K, Nakamura A, Cho KY, Nomoto H, Yamamoto K, Omori K, Manda N, Kurihara Y, Aoki S, Atsumi T. Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study. Endocr J. 2018;65:141-50.
  • Nishioka K, Prayongrat A, Ono K, Onodera S, Hashimoto T, Katoh N, Inoue T, Kinoshita R, Yasuda K, Mori T, Onimaru R, Shirato H, Shimizu S. Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system. J Radiat Res. 2018;59:i63-i71.
  • Kudo D, Hayakawa M, Ono K, Yamakawa K. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study. Thrombosis Research. 2018;163:22-9.
  • Kakutani N, Fukushima A, Yokota T, Katayama T, Nambu H, Shirakawa R, Maekawa S, Abe T, Takada S, Furihata T, Ono K, Okita K, Kinugawa S, Anzai T. Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure. Circulation Journal. 2018;82:2753-60.
  • Honda H, Ono K, Akizawa T, Nitta K, Hishida A. Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis. Clin Exp Nephrol. 2018;22:638-46.
  • Hayakawa M, Ono K. A summary of the Japan septic disseminated intravascular coagulation study. Acute Med Surg. 2018;5:123-8.

和文論文

  • 篠崎 智大, 横田 勲, 大庭 幸治, 上妻 佳代子, 坂巻顕太郎. イベント予測モデルの評価指標. 計量生物学. 2020; 41:1-36.
  • 横田 勲. 生存時間型アウトカムに対する単群試験のデザイン. 日本小児血液・がん学会雑誌. 2019; 56:429-431.
  • 加藤 佑佳, 松田 万祐理, 澤田 親男, 原田 倫治, 山田 美和, 加嶋 晶子, 柏 由紀子, 細井 哲, 横田 勲, 手良向 聡, 成本 迅.高齢統合失調症患者を対象とした抗精神病薬と脂質異常症薬に関する医療同意能力の比較およびデシジョン・エイドによる介入の試み.精神医学 2018;60:75-83.

発表

国際学会

  • Yokota I, Sakamaki K. Regression model for personalized chance of longer survival using pseudo-observations. 41st Annual Conference of the International Society of Clinical Biostatistics, Krakow, Poland (Virtual), Aug 25, 2020.
  • Yokota I, Uemura Y. Using restricted mean survival time in a non-inferiority trial. The VIth International Society for Biopharmaceutical Statistics, Kyoto, Japan, Aug 28, 2019.

国内学会

  • 稲尾 翼, 岡田 和史, 楊 一馳, 横田 勲. 陽性の頻度が稀な診断結果データに対するgold standardな検査法がない場合の感度・特異度推定. 日本分類学会第39回大会. 京都, 2020/11/8.【日本分類学会優秀学生発表賞受賞】
  • 岡田 和史, 土居 正明, 佐藤 俊哉. 中間解析においてヒストリカルデータを利用する臨床試験デザインの提案. 2020年度統計関連学会連合大会, Online, 2020/9/11.
  • 横田 勲. ランドマークモデルによる動的予測. 2018年計量生物セミナー, 京都, 2018/12/7.
  • 横田 勲. 生存時間型アウトカムに対する単群試験のデザイン. 第60回日本小児血液・がん学会学術集会, 2018/11/15.

セミナー

  • 稲尾 翼. 陽性の頻度が稀な診断結果データに対するgold standard がない場合の感度・特異度推定. 第15回Biostatistics Network, Online, 2020/9/5.